Reach Us +44-3308187254


Deepthi Kota | OMICS International
ISSN: 2167-065X

Clinical Pharmacology & Biopharmaceutics
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Deepthi Kota

Novel Laboratories, 400 Campus Drive Somerset, NJ 08873, USA


Deepthi Kota completed her Masters in Pharmaceutical sciences at Campbell University and currently working as Research Scientist at Novel Laboratories, USA. she has co-authored over 100 scientific papers in leading scientific journals and she has written a number of book chapters.

Does Epigallocatechin-3-Gallate-Insulin Complex Protect Human Insulin from Proteolytic Enzyme Action?

Insulin is a polypeptide hormone produced by the β cells present in Islets of Langerhans of the pancreas. Either failure to produce (type 1 diabetes) or utilize insulin (type 2 diabetes) causes diabetes mellitus. Insulin administration is used to treat type 1 diabetes. The common route for insulin administration is via subcutaneous injection. ... Read More»

Antoine Al-Achi and Deepthi Kota

Research Article: Clin Pharmacol Biopharm 2015, 4:139

DOI: 10.4172/2167-065X.1000139

Abstract Peer-reviewed Full Article Peer-reviewed Article PDF